Related News
A £1.65m hope for blood disorder patients is now on offer in Manchester
Reading now: 216
manchestereveningnews.co.ukA £1.65 million treatment has been approved for use for some NHS patients, offering hope of a cure to those with an inherited blood disorder.
Campaigners have shared their joy as health officials approved a gene-editing therapy for certain children and adults with severe sickle cell disorder.
It is estimated that 1,700 people could be eligible after the National Institute for Health and Care Excellence (Nice) approved Casgevy for certain patients with the genetic condition.
NHS officials estimate that around 50 people a year will receive treatment. Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020.
Read more on manchestereveningnews.co.uk
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
